AKOYA BIOSCIENCES INC's ticker is AKYA and the CUSIP is 00974H104. A total of 46 filers reported holding AKOYA BIOSCIENCES INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $771,629 | -89.6% | 329,756 | -79.1% | 0.01% | -87.2% |
| Q1 2024 | $7,409,056 | -3.9% | 1,579,756 | 0.0% | 0.04% | -17.0% |
| Q4 2023 | $7,709,209 | +4.9% | 1,579,756 | 0.0% | 0.05% | -13.0% |
| Q3 2023 | $7,345,865 | -34.4% | 1,579,756 | +4.2% | 0.05% | -3.6% |
| Q2 2023 | $11,199,323 | +4.1% | 1,515,470 | +15.2% | 0.06% | -20.0% |
| Q1 2023 | $10,760,545 | -14.5% | 1,315,470 | 0.0% | 0.07% | -30.0% |
| Q4 2022 | $12,589,048 | -18.6% | 1,315,470 | 0.0% | 0.10% | +2.0% |
| Q3 2022 | $15,457,000 | -8.6% | 1,315,470 | 0.0% | 0.10% | -1.0% |
| Q2 2022 | $16,904,000 | +16.9% | 1,315,470 | 0.0% | 0.10% | +52.3% |
| Q1 2022 | $14,457,000 | -28.2% | 1,315,470 | 0.0% | 0.06% | -14.5% |
| Q4 2021 | $20,140,000 | +35.4% | 1,315,470 | +23.5% | 0.08% | +24.6% |
| Q3 2021 | $14,874,000 | +207.6% | 1,065,470 | +326.2% | 0.06% | +190.5% |
| Q2 2021 | $4,835,000 | – | 250,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 4,697,785 | $22,925,191 | 20.08% |
| Parkman Healthcare Partners LLC | 674,787 | $3,292,961 | 0.46% |
| PEDDOCK CAPITAL ADVISORS, LLC | 290,720 | $1,418,714 | 0.43% |
| Uniplan Investment Counsel, Inc. | 673,523 | $3,421 | 0.25% |
| Kent Lake Capital LLC | 116,835 | $570,155 | 0.22% |
| Board of Trustees of The Leland Stanford Junior University | 620,433 | $3,027,712 | 0.20% |
| SVB WEALTH LLC | 515,317 | $2,514,747 | 0.06% |
| Polar Capital Holdings Plc | 1,579,756 | $7,709,209 | 0.05% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 126,131 | $615,519 | 0.04% |
| ZWJ INVESTMENT COUNSEL INC | 45,175 | $220,454 | 0.01% |